Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022 - Seite 3
This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.
Lesen Sie auch
View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005789/en/
Aktuelle Themen
Weitere Artikel des Autors
2 im Artikel enthaltene WerteIm Artikel enthaltene Werte